<DOC>
	<DOCNO>NCT00210093</DOCNO>
	<brief_summary>The purpose trial characterize pharmacokinetics INS37217 follow intravenous , intranasal , inhalation administration calculate relative bioavailability INS37217 administer via oral nasal inhalation .</brief_summary>
	<brief_title>A Pharmacokinetic Evaluation Study Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Are current nonsmoker previous smoker smoke within 6 month great equal 10 packyear history tobacco use Are within 20 % ideal body weight Are healthy basis pretrial physical examination History suspicion recent alcohol , barbiturate , amphetamine narcotic abuse positive urine drug test study screen History cardiac arrhythmia , pathological abnormality ECG , bronchospasm , diabetes mellitus , thyrotoxicosis , Parkinsonism , asthma , COPD cardiovascular disease significant drug allergy Subject physical obstruction nose Use concomitant medication hormonal contraceptive multivitamin Subjects current upper respiratory illness infection 2 week prior screen chronic respiratory illness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>